NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st October 2019, due to Assembly Elections in Maharashtra.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%
Tue, 13 Aug

NATCO PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m5,3864,5574,9238.0%-8.6%
Other incomeRs m359310210-32.3%-41.5%
TurnoverRs m5,7454,8675,1335.5%-10.7%
ExpensesRs m3,2103,0743,010-2.1%-6.2%
Gross profitRs m2,1761,4831,91329.0%-12.1%
DepreciationRs m1842172201.4%19.6%
InterestRs m28526525.0%132.1%
Profit before taxRs m2,3231,5241,83820.6%-20.9%
TaxRs m51232041028.1%-19.9%
Profit after taxRs m1,8111,2041,42818.6%-21.1%
Gross profit margin%40.432.538.9
Effective tax rate%22.021.022.3
Net profit margin%31.524.727.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 8.6% on a year-on-year (YoY) basis. The expenses were down by 6.2% YoY during the same period.
  • The company's operating profit declined by 12.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 38.9% in 1QFY20 as against 40.4% in 1QFY19.
  • Depreciation charges increased by 19.6% and finance costs increased by 132.1% YoY, respectively.
  • Other income declined by 41.5% YoY during the quarter.
  • Net profit for the quarter declined by 21.1% YoY. Net profit margins during the quarter declined from 31.5% in 1QFY19 to 27.8% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 2.1% QoQ during the same period.
  • The company's operating profit increased by 29.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 38.9% in 1QFY20 as against 32.5% in 4QFY19.
  • Net profit for the quarter increased by 18.6% QoQ, while net profit margins increased from 24.7% in 4QFY19 to 27.8% in 1QFY20.

To see how NATCO PHARMA has performed over the last eight quarters,please visit here.

NATCO PHARMA Share Price Performance

Over the last one year,NATCO PHARMA share price has moved down from Rs 768.0 to Rs 546.4, registering a Loss of Rs 221.6 or around 28.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,722.2 (up 0.2%). Over the last one year it has moved down from 14,332.1 to 12,722.2, a gain of 1,610 points (down 11.2%).

Overall, the S&P BSE SENSEX is down 1.3% over the year.

Current Valuations

At the current price of Rs 546.4, the price to earnings (P/E) ratio of NATCO PHARMA stands at 15.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.0 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS